Today's Pre-Open Stock Movers

Centric Brands Inc. (NASDAQ: CTRC) 52.8% LOWER; announced today that it has entered into a Restructuring Support Agreement (RSA or the agreement) with substantially all of the Companys secured lenders, led by certain funds managed by Blackstone (Blackstone), Ares Management Corporation (Ares), and HPS Investment Partners (HPS), to recapitalize the Company, provide $435 million in debtor-in-possession financing and allow the Company to operate without interruption throughout the restructuring process.

Sorrento Therapeutics (NASDAQ: SRNE) 35.5% HIGHER; Adds to Friday's Gain, Up 35% Pre-Open

Moderna, Inc., (Nasdaq: MRNA) 34.1% HIGHER; announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

Fulgent Genetics, Inc. (NASDAQ: FLGT) 26% HIGHER; announced that its subsidiary, Fulgent Therapeutics, LLC, has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its RT-PCR test for the detection of SARS-CoV-2, the virus that causes COVID-19, using upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs). The company is offering end-to-end processing, analysis and reporting for its COVID-19 tests through its BSL-2, CLIA-certified lab in Temple City, California.

PAR Technologies Ltd. (NYSE: PAR) 20.9% HIGHER; Craig-Hallum initiates coverage on with a Buy rating and a price target of $30.00.

Forescout Technologies, Inc. (Nasdaq: FSCT) 20% LOWER; On May 15, 2020, Advent provided notice to Forescout that it would not be proceeding to consummate the acquisition of Forescout on May 18, 2020, as scheduled. Forescout and Advent are engaged in ongoing discussions regarding timing to close and the terms of the transaction. There can be no assurance that Forescout and Advent will be able to reach agreement on terms.

GSX Techedu Inc. (NYSE: GSX) 18% LOWER; Mentioned as Short at Muddy Waters

Eventbrite Inc. (NYSE: EB) 16.6% HIGHER; SunTrust upgraded from Hold to Buy.

Novavax (NASDAQ: NVAX) 13.5% HIGHER; adds to gains COVID vaccine enthusiasm

Hertz Global Holdings, Inc., (NYSE: HTZ) 13.3% HIGHER; announced that its Board of Directors has named Paul Stone President and Chief Executive Officer, effective immediately. Stone, most recently Hertz's Executive Vice President and Chief Retail Operations Officer, North America, also has been elected to the Hertz Board of Directors. Stone succeeds Kathryn V. Marinello, who plans to continue with the Company in a consulting position for up to one year to support a smooth transition.

BioSig Technologies, Inc. (Nasdaq: BSGM) 7% HIGHER; BioSig Technologies and its majority owned subsidiary, ViralClear Pharmaceuticals, Inc. (ViralClear), today announced that the U.S. Food and Drug Administration (FDA) has completed its review of ViralClears Investigational New Drug (IND) application. The FDA informed ViralClear that it may proceed with a proposed phase II study of merimepodib oral solution in adults with COVID-19 who are hospitalized and either require supplemental oxygen or are on non-invasive ventilation or high flow oxygen devices.

bluebird bio, Inc. (Nasdaq: BLUE) 3.4% LOWER; announced that it has commenced an underwritten public offering of $400 million of its common stock. bluebird bio also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering. All of the shares in the proposed offering are to be sold by bluebird bio.